Related references
Note: Only part of the references are listed.TEG and ROTEM: Technology and clinical applications
David Whiting et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
The Influence of Laboratory Coagulation Tests and Clotting Factor Levels on Rotation Thromboelastometry (ROTEM®) During Major Surgery with Hemorrhage
Oliver M. Theusinger et al.
ANESTHESIA AND ANALGESIA (2013)
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives
Guy Young et al.
BLOOD (2013)
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Corien L. Eckhardt et al.
BLOOD (2013)
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Samantha C. Gouw et al.
BLOOD (2013)
Emergency reversal of heparin overdose in a neurosurgical patient guided by thromboelastography
S. Figueiredo et al.
BRITISH JOURNAL OF ANAESTHESIA (2013)
Consensus recommendations for the use of FEIBA® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery
S. Rangarajan et al.
HAEMOPHILIA (2013)
Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors
L. A. Valentino et al.
HAEMOPHILIA (2013)
Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders
I. Birschmann et al.
HAEMOPHILIA (2013)
Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article
Yvonne Bosch et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2013)
Tranexamic acid in trauma: How should we use it?
Lena M. Napolitano et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2013)
Factor VIII Products and Inhibitors in Severe Hemophilia A
Alfonso Iorio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation
J. H. Foley et al.
ANALYTICAL BIOCHEMISTRY (2012)
Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids
Alexey M. Shibeko et al.
BLOOD (2012)
Thromboelastography in the Assessment of Bleeding Following Surgery for Congenital Heart Disease
Robert A. Niebler et al.
WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY (2012)
Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy
M. Brenni et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2010)
Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery
Yesim Dargaud et al.
BLOOD (2010)
Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immunogenicity in routine clinical practice
J. Oldenburg et al.
HAEMOPHILIA (2010)
Tests of global haemostasis and their applications in bleeding disorders
S. C. Nair et al.
HAEMOPHILIA (2010)
Clinical Utility of Thromboelastography: One Size Does Not Fit All
Julie Wegner et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Thrombin Generation Testing for Monitoring Hemophilia Treatment: A Clinical Perspective
Gian Luca Salvagno et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Platelet binding and activity of recombinant factor VIIa
Maureane Hoffman et al.
THROMBOSIS RESEARCH (2010)
Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors
E. Berntorp
HAEMOPHILIA (2009)
Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thromblogram parameters
Joost J. Van Veen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophofoa A and B patients with inhibitors: a multicentre trial
Guy Young et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
Single 270 mu g kg(-1)-dose rFVIIa vs. standard 90 mu g kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison
G. Young et al.
HAEMOPHILIA (2008)
High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study
M. Besser et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study
Jan Astermark et al.
BLOOD (2007)
Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography
G. Young et al.
HAEMOPHILIA (2006)
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation
Gregor Hron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography
B Sorensen et al.
HAEMOPHILIA (2005)
Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition
R Luddington et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation
B Sorensen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA
S Gallistl et al.
BLOOD COAGULATION & FIBRINOLYSIS (2002)
Share Paper
